Bioreactors Market Will Grow At Highest Pace Owing To Rising Investments In Cell-Based Research

Ashish Thapa

The bioreactors market is used for large-scale production of vaccines, drugs, and cellular products. Bioreactors facilitate mammalian, microbial, and insect cell culture growth to develop vaccines and biologics. They help achieve high cell densities and optimize process parameters like pH levels, gas exchange, nutrition delivery, and waste removal. This ensures consistent and quality production of cellular products on a large scale. With growing investments in cell-based therapies and tissue engineering research, demand for bioreactors is expected to rise sharply.

The Global bioreactors market is estimated to be valued at US$ 23.62 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2030.

Market Trends

Single-use bioreactors are gaining popularity due to advantages like minimized contamination risk, reduced validation requirements, and lower capital investments. Moreover, mobile bioreactors are being used to meet rapidly changing production demands and facilitate on-site manufacturing.

Market Opportunities

Increasing R&D in tissue engineering and regenerative medicine offer lucrative growth opportunities. Rising investments by governments worldwide to promote cell-based research also provides a positive growth environment.

Impact of COVID-19 on Bioreactors Market Growth

The COVID-19 pandemic has impacted the bioreactors market in both negative and positive ways. On the negative side, disruptions in supply chains and lockdowns resulted in delays in new equipment installations and renovation projects. Several planned capacity expansions were also postponed during this period. However, the pandemic also drove up demand for vaccines, therapeutics and diagnostics. This increased the need for bioproduction capabilities and accelerated investments in biomanufacturing infrastructure globally. Many biopharma companies expended efforts to boost production of antibodies, recombinant proteins and other biologically derived products using bioreactors. The pandemic highlighted the importance of ensuring drug security and reducing dependence on offshore suppliers. This has prompted governments and life sciences firms to invest heavily in domestic biomanufacturing facilities equipped with advanced bioreactors. Looking ahead, growth in the bioreactors market is expected to remain strong in the coming years as developers continue working on treatments and preventives for COVID-19 along with other diseases.

Geographical Regions with High Concentration in Bioreactors Market

North America accounts for the largest share of the global bioreactors market in terms of value. This is due to extensive R&D activities in the pharmaceutical and biotechnology sectors in the US and growing biologics manufacturing capabilities in the region. The presence of leading biopharma players and availability of funding for research and development have further augmented market growth. Asia Pacific is emerging as another high growth market for bioreactors driven by rising investments in healthcare infrastructure, increasing incidence of chronic diseases and growing preference for biologics over small molecule drugs. China, India, Japan and South Korea are among the countries contributing significantly to the regional market.

Fastest Growing Regional Market for Bioreactors

Asia Pacific is projected to be the fastest growing regional Bioreactors Market Growth during the forecast period. Rapid economic development, increasing healthcare spending, strong government support for life sciences research and expanding biomanufacturing industries are some of the key factors propelling market expansion in the Asia Pacific region. The presence of low-cost generic manufacturers and contract development and manufacturing organizations has boosted Asia's share in global bioproduction. Additionally, rising patent cliffs have accelerated the shift of biomanufacturing activities to emerging Asian nations like China and India. This is expected to drive higher installation of advanced bioreactors across Asia in the upcoming years.

Key Takeaways

Key players operating in the bioreactors market are Pfizer, Inc., Novartis AG, Kite Pharma, Inc., Bluebird bio, Inc., Becton Dickinson and Company, Amgen, Inc., Vericel Corporation, uniQure N.V., Spark Therapeutics, Inc., Renova Therapeutics, Orchard Therapeutics plc, Kolon Tissue Gene, Inc., Human Stem Cell Institute, Dendreon Pharmaceuticals, Helixmith Co., Ltd (ViroMed Co., Ltd), Bausch & Lomb Incorporated, and Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), among others. Growing demand for biologics and cell therapies has boosted bioreactor adoption across pharmaceutical and biotech firms. Technological advancements like single-use bioreactors and mobile bioreactors have enhanced process flexibility and reduced production costs.

Explore more related article on this topic: https://www.newsstatix.com/the-growing-bioreactors-market-growth-analysis/

Ashish Thapa

Internet Service Providers (Isps) Segment Is Fastest Growing Segment Fueling Growth Of Bioreactors Market

Ashish Thapa 2023-11-14

Their advantages over traditional stainless steel bioreactors such as lower investment costs, ease of use and scalability are fueling adoption among various end users in the bioreactors market. Segment AnalysisThe global bioreactors market is segmented based on product type, component, material, cell, application and end user. Based on product type, the market is segmented into benchtop bioreactor systems, microbioreactors, microcarrier-based bioreactors, stirred tank bioreactors, single-use bioreactors and others. The global Bioreactors Market Share is estimated to be valued at US$ 20. Regional analysis: North America dominates the global bioreactors market and is expected to continue its dominance over the forecast period as well.

Bioreactors Market Size, Drivers, Restraints Challenges, and Growth Opportunities Till 2027

Mariya Ahsan 2021-12-29

The Bioreactors Market Report, in its latest update, highlights the significant impacts and the recent strategical changes under the present socio-economic scenario. Get | Download FREE Sample Report of Global Bioreactors Market @ https://www. Which application and type segment holds the maximum share in the Global Bioreactors market? What are the opportunities and challenges currently faced by the Bioreactors market? Purchase the Complete Global Bioreactors Market Research Report @ https://www.

The global bioreactors market Growth Accelerated by Increasing Adoption of Single-use Bioreactors

Ishika cmi 2024-01-12

The bioreactors market includes instruments used for mammalian, microbial, and cell culture growth in the biotechnology and pharmaceutical industry. The global bioreactors market is estimated to be valued at US$ 20. Their widespread acceptance is expected to boost revenue generation in the global bioreactors market during the forecast period. Segment Analysis The global bioreactors market growth is dominated by single-use bioreactors sub-segment which occupied over 50% of the total market share in 2022. The global bioreactors market is estimated to be valued at US$ 20. Novartis AG provides fluid management systems and single-use bioreactors for cell and gene therapy applications.

Bioreactors Market Impact of Covid-19

Data Bridge Market Research 2022-03-14

The Bioreactors Market is expected to witness market growth at a rate of 14. The Bioreactors Market Scope and SizeA market research conducted in the world class Bioreactors Market research report aids in improving and modifying the products so that future products present more satisfaction to the valuable customers. By keeping in mind the end user’s point of view, a team of researchers, forecasters, analysts and industry experts work in-depth to structure this market research report. dbmr=global-bioreactors-marketAn observant efforts accompanied with integrated approaches and sophisticated techniques results into an excellent market research report that drives the decision making process of the business. This Bioreactors Market report covers company profiling of key players in the market, carefully analyzing their core competencies, and drawing a competitive landscape for the market.

Bioreactors Market Is Estimated To Witness High Growth Owing To Growing Biopharmaceutical Industry

Omkar Patel 2023-12-20

The bioreactors market is estimated to be valued at US$ 20. This is estimated to support the market growth over the forecast period. Regional analysis North America dominated the global bioreactors market in 2023, accounting for around 35% share. Asia Pacific is poised to be the fastest growing market for bioreactors exhibiting over 13% CAGR during the forecast period. Increasing government investments to foster biotech startups, rising contract manufacturing activity and growing health awareness are fueling regional market growth.

The Perfusion Bioreactors Market to Grow Beyond Linear Progression

Jayprakash Sharma 2022-03-29

The Perfusion Bioreactors Market is expected to grow on an unabashed note in the next decade. The global perfusion bioreactors market was valued around US$ 300 Mn in 2020, and is expected to exhibit a CAGR of around 7. The region of North America is dominant in the global market for perfusion bioreactors, and will continue to remain the most lucrative market over the forecast period. However, the global perfusion bioreactors market can be said to be minimally affected. comWebsite – https://www.

WHO TO FOLLOW